Exploring some potential biomarkers and mediators in diabetes complications: Focus on foot ulcer disease, and NAFLD

Speaker: 
Professor Stephen Twigg
Affiliation: 
Royal Prince Alfred Hospital (RPAH), Sydney, and Sydney Medical School and the Charles Perkins Centre, the University of Sydney
Date: 
26 May 2017 - 3:00pm
Venue: 
Rountree Room 356, Level 3, Biological Sciences Building D26
Abstract: 

None provided.

Biography: Professor Stephen Twigg, MBBS(Hons-I), PhD(Syd), FRACP, is Head of the Dept of Endocrinology, and the Endocrinology Research Laboratories, Royal Prince Alfred Hospital (RPAH), Sydney, and Kellion Professor of Endocrinology, Stan Clark Chair in Diabetes, in Sydney Medical School and the Charles Perkins Centre, the University of Sydney. As a physician-scientist his program of research since 1995 has been dedicated to preventing, and managing end-organ complications in diabetes, including foot disease, and more recently, liver disease in diabetes. Steve’s main translational interest is how diabetes causes tissue damage with loss of function, and ways this can be addressed to improve clinical outcomes. He has published more than 160 articles in peer-reviewed journals, mainly in translational research in diabetes and its diabetes complications, and holds international and national competitive grant funding in diabetes, currently supervising 6 PhD students. His H-factor is 47, with 6,800 citations. He is an Associate Editor of the Journal of Diabetes and its Complications, a past-President of the Australian Diabetes Society, an Australian delegate to the IDF General Assembly, and has chaired National Health and Medical Research Council (NHMRC) of Australia clinical care guidelines development in type 1 diabetes. He is course convenor of the international Masters of Metabolic Health at the University of Sydney, and has delivered national and international presentations in diabetes, including at the IDF World Global Congress, the ADA Annual Scientific sessions, and in many countries in Asia. He has been on the IDF-WPR Foot Network for Australia and has recently commenced as Chair of the Australian Diabetes Foot Network of the National Association of Diabetes Centres. His presentation will focus on key aspects of multidisciplinary diabetes liver disease and diabetes foot care and some potential markers and mediators of these complications.